Capecitabine and PPE syndrome: a case report.
LoRusso
Patricia M
PM
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D001943:Breast Neoplasms / Q000188:drug therapy; D000069287:Capecitabine; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004890:Erythema / Q000139:chemically induced*; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives; D005528:Foot; D006225:Hand; D006801:Humans; D008875:Middle Aged; D010292:Paresthesia / Q000139:chemically induced*; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil